8-K
filed April 14, 2025, 7:59 PM ET
ticker ANEB
CIK 0001815974
other material
confidence high
sentiment neutral
materiality 0.40
Anebulo shareholders approve authorized share increase to 75M and board declassification
Anebulo Pharmaceuticals, Inc.
- Stockholders approved raising authorized common shares from 50M to 75M at the April 4, 2025 Annual Meeting.
- Certificates of amendment filed with Delaware on April 11, 2025.
- Stockholders also approved declassification of the Board; all directors will stand for annual election starting next meeting.
- Board adopted conforming Bylaws amendment effective upon the declassification charter amendment.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Anebulo Pharmaceuticals, Inc.: Conforming amendment to Bylaws related to board declassification (effective 2025-04-11).
- Change
- bylaw amendment
- Effective
- 2025-04-11
Exact text from the filing
On April 11, 2025, the Company’s Board of Directors approved an amendment (the “ Bylaws Amendment ”) to the Amended and Restated Bylaws of the Company (the “ Bylaws ”) to include conforming language related to the board declassification in the Company’s Bylaws.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Anebulo Pharmaceuticals, Inc.: Declassify Board of Directors, directors to stand for election annually (effective 2025-04-11).
- Change
- charter amendment
- Effective
- 2025-04-11
Exact text from the filing
On April 11, 2025, the Company filed the Declassification Charter Amendment with the Secretary of State of the State of Delaware.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Anebulo Pharmaceuticals, Inc.: Increase authorized common stock from 50M to 75M (effective 2025-04-11).
- Change
- charter amendment
- Effective
- 2025-04-11
Exact text from the filing
On April 11, 2025, the Company filed the Share Increase Amendment with the Secretary of State of the State of Delaware.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.